Drug intelligence / Profile preview

Yangxue Guben

Development stage: Unknown
Lead developer: Jilin Fukang Pharmaceutical
Modality: Small Molecules
Administration: Oral

Overview

Yangxue Guben (also known as Yangxue Guben Capsules) is a traditional Chinese medicine (TCM) developed and marketed by Jilin Fukang Pharmaceutical. As an exclusive product of the company, it is formulated to nourish the blood and consolidate the root, a therapeutic principle in TCM used to address blood deficiency and general physical weakness. The product is typically administered orally in capsule form. While the specific molecular targets are not disclosed, the formulation is intended to treat symptoms such as dizziness, palpitations, and fatigue associated with blood deficiency syndromes. It is classified as a Chinese Patent Medicine (Zhongchengyao) and is approved for marketing in China.

Brand names: Yangxue Guben Capsules养血固本胶囊
Other names: Yangxue Guben Jiaonang

Beyond the preview

Go deeper on Yangxue Guben.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Yangxue Guben.

Explore the full profile